Clinical Trial Update: Effects of Teriflunomide (Aubagio) on Cognitive and Vocational Outcomes in Multiple Sclerosis

View source ↗

Summary

Clinical trial assessing teriflunomide (Aubagio) impact on cognitive and vocational outcomes in multiple sclerosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Teriflunomide (teriflunomide)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Multiple Sclerosis | Status: COMPLETED | Results posted: 2021-09-24